Article Highlights
Serum urate level governs management of difficult-to-treat gout
Take drug, patient-level factors into account for when to end antiresorptive therapy
Cannabinoids, stem cells lack evidence for osteoarthritis, expert says
Set reasonable expectations for managing refractory rheumatoid arthritis
Consider centralized pain in patients with rheumatic disease
Jointly Provided By
In Association With
